Publications by authors named "Naama Rotenberg"

Claim this Profile
E
Engineered protein inhibitors for precise targeting of matrix metalloproteinases.
Naama Rotenberg, Noam Y Bentolila, Julia M Shifman

Trends Biochem Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity.
Mark Feldman, Naama Rotenberg, Julia M Shifman

Biomolecules· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mirror-Image Random Nonstandard Peptides Integrated Discovery (MI-RaPID) Technology Yields Highly Stable and Selective Macrocyclic Peptide Inhibitors for Matrix Metallopeptidase 7.
Hiba Ghareeb, Choi Yi Li, Anjana Shenoy, Naama Rotenberg, Julia M Shifman

Angew Chem Int Ed Engl· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells.
Naama Rotenberg, Mark Feldman, Jason Shirian, Alexandra Hockla, Evette S Radisky

J Biol Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
Jason Shirian, Alexandra Hockla, Justyna J Gleba, Matt Coban, Naama Rotenberg

Biomolecules· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
Jason Shirian, Alexandra Hockla, Justyna J Gleba, Matt Coban, Naama Rotenberg

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis